Cargando…

Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’

Detalles Bibliográficos
Autores principales:	Bakalos, Georgios, Schreitmüller, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663272/ https://www.ncbi.nlm.nih.gov/pubmed/29104764 http://dx.doi.org/10.1136/esmoopen-2017-000281

Ejemplares similares

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
por: Tabernero, Josep, et al.
Publicado: (2017)

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
por: Giuliani, Rosa, et al.
Publicado: (2019)

The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
por: Fernandes, G.S., et al.
Publicado: (2018)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018)

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
por: Ferrari, A., et al.
Publicado: (2021)

Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing
por: Cook, John W., et al.
Publicado: (2019)

European Society for Medical Oncology 2020
por: Bartsch, Rupert
Publicado: (2021)

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
por: Kyrgiou, Maria, et al.
Publicado: (2020)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

AllergoOncology – the impact of allergy in oncology: EAACI position paper
por: Jensen‐Jarolim, E., et al.
Publicado: (2017)

Clinical considerations for the development of biosimilars in oncology
por: Socinski, Mark A, et al.
Publicado: (2015)

Preparing for the incoming wave of biosimilars in oncology
por: Wolff-Holz, Elena, et al.
Publicado: (2018)

AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
por: Bergmann, Christoph, et al.
Publicado: (2022)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

In Reply: Bringing Retracted Papers Into Focus
por: Kim, Joon Ho, et al.
Publicado: (2015)

Development of biosimilars in an era of oncologic drug shortages
por: Li, Edward, et al.
Publicado: (2015)

Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015)

Correction: Preparing for the incoming wave of biosimilars in oncology
Publicado: (2018)

Barriers to Oncology Biosimilars Uptake in the United States
por: Nabhan, Chadi, et al.
Publicado: (2018)

The role of biosimilars in value-based oncology care
por: Patel, Kashyap B, et al.
Publicado: (2018)

Current and future roles of biosimilars in oncology practice
por: Konstantinidou, Sofia, et al.
Publicado: (2020)

Biosimilars in Oncology: Latest Trends and Regulatory Status
por: Joshi, Deeksha, et al.
Publicado: (2022)

Oncology biosimilars: New developments and future directions
por: Bachu, Rinda Devi, et al.
Publicado: (2022)

Conference Report: European Society for Medical Oncology Congress 2022
por: Dogan, Sevda
Publicado: (2023)

Reply to Haynes et al.: Calibration Myths in the 2019American Thoracic Society/European Respiratory Society Spirometry Technical Standards
por: Graham, Brian L., et al.
Publicado: (2020)

Reply to Townsend: The American Thoracic Society/European Respiratory Society 2019 Spirometry Statement and Occupational Spirometry Testing in the United States
por: Graham, Brian L., et al.
Publicado: (2020)

Presently available biosimilars in hematology-oncology: G-CSF
por: Gascon, Pere
Publicado: (2012)

Biosimilar agents in oncology/haematology: from approval to practice
por: Niederwieser, Dietger, et al.
Publicado: (2011)

Biosimilars in the United States: Considerations for Oncology Advanced Practitioners
por: Mayden, Kelley D., et al.
Publicado: (2015)

Integrating Biosimilars Into Oncology Practice: Implications for the Advanced Practitioner
por: Campen, Christopher J.
Publicado: (2017)

Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016)

2018 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists
por: Patrikos, Dimos, et al.
Publicado: (2019)

After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
por: Kim, Miseon, et al.
Publicado: (2019)

Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European Society of Oncologic Imaging
por: Neri, Emanuele, et al.
Publicado: (2020)

The Rationale of Malaria Therapy in Late Localized Syphilis with Particular Reference to General Paralysis of the Insane
por: Brooks, A. G.
Publicado: (1947)

AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper
por: Untersmayr, Eva, et al.
Publicado: (2019)

Broadening the scope of artificial intelligence in oncology
por: Ravella, Revathi, et al.
Publicado: (2023)

Extrapolation concept at work with biosimilar: a decade of experience in oncology
por: Krendyukov, Andriy, et al.
Publicado: (2018)

Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars
por: Stebbing, Justin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n7sclgfjgb0pu0p4vj3u63j9uo